Results 91 to 100 of about 2,926 (207)

Speculation and Justification in Policy-Making on Neuroenhancement [PDF]

Los descubrimientos de las neurociencias permiten intervenir en el cerebro humano para mejorar su estado o sus capacidades sin indicación médica. Este fenómeno es conocido como “Neuroenhancement” y está sujeto a un amplio debate ético.
Schlag, Stefan
core  

Robust resilience and substantial interest: a survey of pharmacological cognitive enhancement among university students in the UK and Ireland [PDF]

, 2014
Use of ‘smart drugs’ among UK students is described in frequent media reports as a rapidly increasing phenomenon. This article reports findings from the first large-scale survey of pharmacological cognitive enhancement (PCE) among students in the UK and ...
Bard, Imre, Jackson, Jonathan, Singh, Ilina   +2 more
core   +2 more sources

Outsmarted by nooptropics? An investigation into the thermal degradation of modafinil, modafinic acid, adrafinil, CRL-40,940 and CRL-40,941 in the GC injector: formation of 1,1,2,2-tetraphenylethane and its tetra fluoro analog. [PDF]

2-[(Diphenylmethyl)sulfinyl]acetamide (modafinil) is commonly prescribed for the treatment of narcolepsy and increasing popularity and off-label use as a cognitive enhancer resulted in a reputation as an intelligence boosting ‘wonder drug’.
Battledaya, Becue, Biovin, Bohne, Bohnenberger, Bowie, Burnat, Cao, Dackis, Dackis, Dackis, Dietz, Dolomanov, Dougherty, Duan, Dubey, Forrester, Hart, Jean-Pierre, Jockusch, Johnstone, Jurie, Kahbazi, Kampman, Kelley, Khuddus, Kumar, Lange, Ma, Maher, Malcolm, McKinney, Milgram, Minkwitz, Minzenberg, Moreau, Ondo, Rabkin, Randall, Robertson, Schmitz, Schmitz, Sheldrick, Topolyan, Tseng, Tsujikawa, Tsurugi, Turner, Williams, Williams, Wu   +50 more
core   +1 more source

Evaluating the drivers of and obstacles to the willingness to use cognitive enhancement drugs: the influence of drug characteristics, social environment, and personal characteristics [PDF]

, 2014
Sattler S, Mehlkop G, Graeff P, Sauer C. Evaluating the drivers of and obstacles to the willingness to use cognitive enhancement drugs: the influence of drug characteristics, social environment, and personal characteristics.
A Bandura, A Chatterjee, A Franke, A Looby, AD Ong, AG Franke, AG Franke, AG Franke, AJ Elliot, AM Arria, B Sahakian, C Ames, C Kroneberg, C Midgley, C Normann, C Ragan, C Winship, Carsten Sauer, CH Lay, CJ Teter, CP Müller, CR Tittle, CS Alexander, D Repantis, DC Randall, DL Rabiner, DL Rabiner, DM Tice, DS Nagin, E Braun, E Middendorff, E Racine, EL Deci, F Kreuter, FX Gibbons, G Jasso, G Ramirez, GS Becker, Guido Mehlkop, H Dülmer, H Greely, HG Grasmick, I Ajzen, J Hilbe, J Musch, JA Ford, JA Ouellette, JM Harackiewicz, JW Graham, K Grayson, K-D Opp, K-P Wild, KD Wason, L Wallander, LA Kroutil, LL Weyandt, M Gerrard, M Husain, M Smith, M Zeidner, MJ Farah, ML Eaton, MM Ali, MW Eysenck, MW Eysenck, N Bavarian, N Bostrom, ND Volkow, P Choong, P Dietz, P Steel, Peter Graeff, R Judson, R Tourangeau, RB Cialdini, RM Klassen, RM Ryan, S Castaldi, S Kulis, S Mache, S Sattler, S Sattler, S Sattler, S Sattler, S Sussman, S Tobias, SE McCabe, SE McCabe, SE McCabe, SE Winder-Rhodes, Sebastian Sattler, SP Novak, SPR Rose, T Bennett, T Dohmen, T Voss, TW Valente, U Schiefele, V Dubljevic, V Hodapp, V Hodapp, W Glannon, W Wolff, WD Foglia, Z MacDonald   +104 more
core   +2 more sources

ePoster

European Journal of Neurology, Volume 32, Issue S1, June 2025.
wiley   +1 more source

Neuroenhancement and neuroprotection by oral solution citicoline in non-arteritic ischemic optic neuropathy as a model of neurodegeneration: A randomized pilot study.

PLoS ONE, 2019
PurposeTo evaluate whether treatment with Citicoline in oral solution (OS-Citicoline) would increase visual function, retinal ganglion cells (RGCs) function, and neural conduction along visual pathways (neuroenhancement), and/or induce preservation of ...
Vincenzo Parisi, Lucilla Barbano, Antonio Di Renzo, Gianluca Coppola, Lucia Ziccardi   +4 more
doaj   +1 more source

Functional imaging in neuroenhancement

, 2020
Increasingly demanding tasks, competition for competence and time pressure have lead to attempts of neuroenhancement (NE) among students and employees. NE is designed to increase cognitive abilities by modulating brain processes through the use of pharmaceutics. Substances such as methylphenidate (i.e. Ritalin®), modafinil (i.e.
openaire   +1 more source

Neuroenhancement in Military Personnel:

, 2023
Military personnel face harsh conditions that strain their physical and mental well-being, depleting resources necessary for sustained operational performance. Future operations will impose even greater demands on soldiers in austere environments with limited support, and new training and technological approaches are essential.
van Erp, Jan B.F., Beaudoin, Monique E., Brunyé, Tad T., Feltman, Kathryn A., Greenwald, Hal, Heaton, Kristin J., McKinley, Richard A., Vartanian, Oshin, Vergin, Annika, Whittaker, Annalise, Wester, Brock, Ohiri, Korine, Hamilton, Leslie   +12 more
openaire   +1 more source

Cigarette Smoking, Risky Alcohol Consumption, and Marijuana Smoking among University Students in Germany: Identification of Potential Sociodemographic and Study-Related Risk Groups and Predictors of Consumption. [PDF]

Healthcare (Basel), 2023
Hoff TA, Heller S, Reichel JL, Werner AM, Schäfer M, Tibubos AN, Simon P, Beutel ME, Letzel S, Rigotti T, Dietz P.   +10 more
europepmc   +1 more source

Pharmacological Neuroenhancement: teachers’ knowledge and attitudes–Results from a survey study among teachers in Germany [PDF]

, 2016

core   +1 more source